SEC Filing Summary: SANUWAVE Health, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by SANUWAVE Health, Inc., a Nevada corporation, on August 24, 2016. The report details the entry into a material definitive agreement regarding a private placement of securities. The company is headquartered in Suwanee, Georgia.
Key Financial Metrics and Transaction Details
The filing discloses a specific capital raise transaction rather than periodic financial performance metrics such as revenue or operating margins. Key transaction figures include:
- Securities Issued: 22,766,667 shares of Common Stock.
- Aggregate Purchase Price: $1,366,000.
- Warrants Issued: 22,766,667 Class L Warrants.
- Warrant Exercise Price: $0.08 per share.
- Warrant Expiration: March 17, 2019.
- Use of Proceeds: Working capital and general corporate purposes.
The filing text does not provide clear values for the company's current revenue, profit, cash flow, debt levels, or liquidity ratios outside of the proceeds from this specific offering.
Material Changes and Related Parties
The primary material change is the execution of a Securities Purchase Agreement with accredited investors. Notably, the transaction involved related parties:
- Anthony M. Stolarski, a board member and existing shareholder.
- Michael Nemelka, the brother of a board member and an existing shareholder.
The offering is expected to close on or about August 25, 2016.
Guidance, Risks, and Contingencies
Forward-Looking Statements: The filing contains standard cautionary language regarding forward-looking statements, noting that actual results may differ due to risks and uncertainties.
Registration Rights and Penalties: The company entered into a Registration Rights Agreement requiring the filing of a registration statement for the resale of the issued securities. Failure to meet specific deadlines in this agreement may subject the company to monetary penalties.
Exemptions: The sale of securities is exempt from registration under Section 4(a)(2) of the Securities Act and Regulation D. No general solicitation or advertising was used.
Investor Verification Checklist
- Verify the closing date of the offering (expected August 25, 2016) and confirmation of fund receipt.
- Review the full text of the Registration Rights Agreement (Exhibit 10.2) to understand specific deadlines and potential monetary penalties.
- Confirm the dilution impact of 22,766,667 new shares and the associated warrants on existing shareholders.
- Check subsequent filings for the registration statement required for the resale of these securities.
- Review the company's most recent Form 10-K for baseline financial health, as this 8-K does not contain comprehensive financial statements.